Our latest insights

What We're Thinking

After putting your career on pause, it can be challenging to get it back. In this post, Mix Talent’s Jill Purdy writes about how she did it – and how you can, too.

While successful leadership transitions are extremely important for businesses, they don’t usually go as smoothly as you hope – but coaching can change that.

Learn how life sciences leaders can balance the pros and cons of Artificial Intelligence in their recruiting and talent optimization efforts.

Mix Talent is recognizing Rare Disease Day 2024 by celebrating rare heroes from across the country whose initiative, advocacy, and perseverance are making a difference in the lives of others.

After the positive reception to our inaugural Trends Report, we’re excited to introduce our 2024 Trends Report. Beyond reporting on what we learned, we have also added commentary throughout based on what we have seen transpire in life sciences talent this past year and how we expect it to evolve in the year to come.

In part 2 of our Special Edition Series - Cell and Gene Tx Journey to Commercialization - Abbey Jenkins (CEO, Gamida Cell) and Izzy Tyszler (VP of Commercial, Zevra Therapeutics) join ADVI Health’s Director of Health Policy and Reimbursement, Alicia Silver, to discuss commercialization of gene and cell therapies. Abbey and Izzy share their key learnings from past experiences leading commercial teams, including advice on how best to prepare for commercialization.

Scroll to Top

Let's Mix!

If you’d like to learn more about what we do, get in touch and discover how we can help you make it happen.

10 Talent Trends
for the Life Sciences in 2024

Stay on top of a shifting life sciences landscape